Shu‐Xiang Cui

2.4k total citations
69 papers, 1.8k citations indexed

About

Shu‐Xiang Cui is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shu‐Xiang Cui has authored 69 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 28 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Shu‐Xiang Cui's work include Peptidase Inhibition and Analysis (12 papers), Sphingolipid Metabolism and Signaling (9 papers) and Protease and Inhibitor Mechanisms (7 papers). Shu‐Xiang Cui is often cited by papers focused on Peptidase Inhibition and Analysis (12 papers), Sphingolipid Metabolism and Signaling (9 papers) and Protease and Inhibitor Mechanisms (7 papers). Shu‐Xiang Cui collaborates with scholars based in China, Japan and Canada. Shu‐Xiang Cui's co-authors include Xian‐Jun Qu, Xinfeng Yu, Zhiyu Song, Xiaohui Wang, Shiyue Sun, Wei Tang, Juan Yang, Zu‐Hua Gao, Haochen Wu and Dong Wang and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Shu‐Xiang Cui

67 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu‐Xiang Cui China 24 1.0k 546 428 299 152 69 1.8k
Wen‐Sheng Wu Taiwan 22 1.0k 1.0× 360 0.7× 273 0.6× 181 0.6× 105 0.7× 41 1.8k
Chunping Jiang China 27 1.3k 1.3× 850 1.6× 495 1.2× 224 0.7× 189 1.2× 66 2.2k
Jie Ji China 21 1.2k 1.1× 766 1.4× 370 0.9× 369 1.2× 230 1.5× 74 2.1k
Ming‐Shyue Lee Taiwan 28 1.2k 1.2× 427 0.8× 405 0.9× 263 0.9× 89 0.6× 52 2.2k
Dae‐Ghon Kim South Korea 28 1.3k 1.2× 577 1.1× 365 0.9× 156 0.5× 254 1.7× 49 2.1k
Jinliang Yang China 29 1.3k 1.2× 256 0.5× 566 1.3× 276 0.9× 169 1.1× 109 2.7k
Anju Shrivastava India 24 834 0.8× 292 0.5× 359 0.8× 357 1.2× 286 1.9× 91 1.8k
Leina Ma China 24 1.6k 1.6× 793 1.5× 536 1.3× 186 0.6× 151 1.0× 50 2.2k

Countries citing papers authored by Shu‐Xiang Cui

Since Specialization
Citations

This map shows the geographic impact of Shu‐Xiang Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Xiang Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Xiang Cui more than expected).

Fields of papers citing papers by Shu‐Xiang Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Xiang Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Xiang Cui. The network helps show where Shu‐Xiang Cui may publish in the future.

Co-authorship network of co-authors of Shu‐Xiang Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Xiang Cui. A scholar is included among the top collaborators of Shu‐Xiang Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Xiang Cui. Shu‐Xiang Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Zhikun, Xinfeng Wu, Ming Tan, et al.. (2025). Activation of sphingosine-1-phosphate receptor 2 (S1PR2) upregulates dihydropyrimidine dehydrogenase (DPD) expression in colon cancer cells. Journal of Advanced Research. 77. 497–511.
2.
Luo, Dongdong, Xiaochun Liu, Zhikun Guo, et al.. (2022). Rational Design, Synthesis, and Biological Evaluation of Novel S1PR2 Antagonists for Reversing 5-FU-Resistance in Colorectal Cancer. Journal of Medicinal Chemistry. 65(21). 14553–14577. 6 indexed citations
3.
Cui, Shu‐Xiang, et al.. (2022). Intestinal aberrant sphingolipid metabolism shaped‐gut microbiome and bile acids metabolome in the development of hepatic steatosis. The FASEB Journal. 36(8). e22398–e22398. 15 indexed citations
4.
Guo, Zhikun, Shuai Zhang, Xiaochun Liu, et al.. (2022). Design, synthesis, and evaluation of JTE-013 derivatives as novel potent S1PR2 antagonists for recovering the sensitivity of colorectal cancer to 5-fluorouracil. Bioorganic Chemistry. 131. 106318–106318. 4 indexed citations
5.
Yang, Juan, et al.. (2022). Atypical chemokine receptor 3 induces colorectal tumorigenesis in mice by promoting β-arrestin-NOLC1-fibrillarin-dependent rRNA biogenesis. Acta Pharmacologica Sinica. 43(11). 2967–2976. 7 indexed citations
6.
Shi, Wenna, Shuhua Wu, Shiyue Sun, et al.. (2020). SphK2 confers 5-fluorouracil resistance to colorectal cancer via upregulating H3K56ac-mediated DPD expression. Oncogene. 39(29). 5214–5227. 30 indexed citations
7.
8.
Meng, Jianping, Xiaoling Zhou, Juan Yang, Xian‐Jun Qu, & Shu‐Xiang Cui. (2020). Exposure to low dose ZnO nanoparticles induces hyperproliferation and malignant transformation through activating the CXCR2/NF-κB/STAT3/ERK and AKT pathways in colonic mucosal cells. Environmental Pollution. 263(Pt B). 114578–114578. 14 indexed citations
9.
Zhou, Xiaoling, et al.. (2020). M10, a Myricetin-3-O-b-D-Lactose Sodium Salt, Prevents Ulcerative Colitis Through Inhibiting Necroptosis in Mice. Frontiers in Pharmacology. 11. 557312–557312. 24 indexed citations
10.
Guo, Caixia, Ji Wang, Man Yang, et al.. (2017). Amorphous silica nanoparticles induce malignant transformation and tumorigenesis of human lung epithelial cells via P53 signaling. Nanotoxicology. 11(9-10). 1176–1194. 52 indexed citations
11.
Zhang, Yusheng, Ye Li, Yan Wang, et al.. (2015). Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc Min/+ mouse model. Journal of Cancer Research and Clinical Oncology. 142(5). 913–925. 27 indexed citations
12.
Zhang, Yusheng, Jiahui Chu, Zhiyu Song, Shu‐Xiang Cui, & Xian‐Jun Qu. (2015). Des-Gamma-Carboxy Prothrombin (DCP) Antagonizes the Effects of Gefitinib on Human Hepatocellular Carcinoma Cells. Cellular Physiology and Biochemistry. 35(1). 201–212. 13 indexed citations
13.
Liu, Huiping, Zu‐Hua Gao, Shu‐Xiang Cui, et al.. (2012). Inhibition of Intestinal Adenoma Formation in APCMin/+ Mice by Riccardin D, a Natural Product Derived from Liverwort Plant Dumortiera hirsuta. PLoS ONE. 7(3). e33243–e33243. 21 indexed citations
14.
Liu, Huiping, Zu‐Hua Gao, Shu‐Xiang Cui, et al.. (2012). Chemoprevention of intestinal adenomatous polyposis by acetyl‐11‐keto‐beta‐boswellic acid in APCMin/+ mice. International Journal of Cancer. 132(11). 2667–2681. 38 indexed citations
15.
Pan, Yue, Zu‐Hua Gao, Xue Xia, et al.. (2011). Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway. European Journal of Cancer. 47(7). 1115–1124. 36 indexed citations
16.
Sun, Lirui, Julia Li Zhong, Shu‐Xiang Cui, et al.. (2010). Modulation of P-glycoprotein activity by the substituted quinoxalinone compound QA3 in adriamycin-resistant K562/A02 cells. Pharmacological Reports. 62(2). 333–342. 5 indexed citations
17.
Cui, Shu‐Xiang, Xian‐Jun Qu, Zu‐Hua Gao, et al.. (2009). Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells. Cancer Letters. 292(2). 153–162. 41 indexed citations
18.
Cui, Shu‐Xiang, Minghui Chen, Yanna Cheng, et al.. (2008). Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells. Life Sciences. 83(23-24). 815–820. 38 indexed citations
19.
Qu, Xian‐Jun, Yunxia Yuan, Zhigang Tian, et al.. (2006). Using caffeoyl pyrrolidine derivative LY52, a potential inhibitor of matrix metalloproteinase-2, to suppress tumor invasion and metastasis. International Journal of Molecular Medicine. 18(4). 609–14. 10 indexed citations
20.
Qu, Xian‐Jun, et al.. (2000). Antitumor studies on the polysacchrides Spirulina platensis. Europe PMC (PubMed Central). 19(4). 10–14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen‐Sheng Wu Breakdown of academic impact, for papers by Chunping Jiang Breakdown of academic impact, for papers by Jie Ji Breakdown of academic impact, for papers by Ming‐Shyue Lee Breakdown of academic impact, for papers by Dae‐Ghon Kim Breakdown of academic impact, for papers by Jinliang Yang Breakdown of academic impact, for papers by Anju Shrivastava Breakdown of academic impact, for papers by Leina Ma
Rankless by CCL
2026